APH · Verdict

A summary of rules, not a profit forecast — don’t buy just because of a green verdict.

• ▼ P/E 34.3 vs peer median 30.7 — more expensive than peers
• ▼ P/S 5.9 — expensive for this stock (over 10 y: from 3.1 to 7.5)
• ▼ P/S 5.9 vs peer median 4.5 — more expensive than peers
• ▼ EV/EBITDA 19.1 vs peer median 14.1 — more expensive than peers
• ▼ FCF yield 2.2% — expensive for this stock (over 10 y: from 2.2% to 4.2%)
• ▼ FCF yield 2.2% vs peer median 3.0% — more expensive than peers
• ▼ Cyclical company at peak earnings: P/E 34.3 is understated; on average earnings over 10 y it is 116.1
• ▲ Forward P/E 22.1 is below the current one — earnings growth expected

• ▼ Debt up 239% in 3 y
• ▲ Has raised its dividend 14 years in a row
• ▲ ROE 40% — high return on equity
• ▲ Net margin rose: 15.1% → 18.5%
• ▲ Free cash flow positive every year

• ▲ Revenue grows 21.8% per year (5 y)
• ▲ Earnings per share grows 27.8% per year (5 y)
• ▲ Analysts raised the earnings forecast by +6.7% in 90 days

• ▲ Price above SMA200 — long-term uptrend
• ▲ SMA50 above SMA200 — trend up

• ▼ Risk/reward 1:0.9 — the target is closer than the stop
• ▼ Volatility 46% per year — much higher than the market (13%)

• ▲ Consensus of 19 analysts — buy
• ▲ Mean analyst target +34% from the current price
• ▲ Insiders buying over 6 mo

• ▲ S&P 500 above SMA200 — the market is in an uptrend
• ▲ Sector (XLK) above SMA200 — in an uptrend